Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Estrella Immunopharma (ESLA)

Annual Return

Over the past 3 years, ESLA has had an average annual return of -53.77%, underperforming the benchmark SPY, which returned +22.77% annual.

Since Sep 14, 2021, ESLA has had an average annual return of -37.27%, underperforming the benchmark SPY, which returned +13.60% annual.

202620252024202320222021
-30.75%+29.98%+8.17%-89.22%+3.84%+1.64%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-28.19%+8.88%-13.11%+54.74%-33.53%-0.89%-30.75%
2025-12.51%-1.95%-9.94%+16.51%-6.59%-4.83%-12.49%+24.94%+9.47%+110.52%-12.81%-26.06%+29.98%
2024+0.97%-8.96%+21.61%-15.33%-9.84%+10.92%+48.56%-19.25%-7.89%-31.09%+41.95%+5.76%+8.17%
2023+3.70%+0.56%-1.40%+1.04%+0.28%+1.12%-7.11%-27.51%+27.94%-82.87%+3.78%-33.18%-89.22%
2022+0.30%+0.10%+0.40%+0.20%+0%-0.11%+0.51%+0%+0.10%+0.40%+2.47%-0.57%+3.84%
2021+1.54%+0.20%+0.61%-0.70%+1.64%

Drawdown analysis of Estrella Immunopharma (ESLA)

The maximum drawdown for the ESLA was -96.58%, occurring on Nov 1, 2024. This drawdown has not yet recovered.

The current ESLA drawdown is -94.92%.

Since Sep 14, 2021 ESLA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-96.58%Sep 1, 2023294Nov 1, 2024OngoingOngoingOngoing
-35.78%Aug 1, 202319Aug 28, 20234Sep 1, 202323
-9.92%Jul 17, 20237Jul 26, 20234Aug 1, 202311
-4.95%May 25, 202221Jun 27, 2022149Jan 30, 2023170
-4.36%May 16, 20235May 23, 202335Jul 14, 202340
-2.72%Jan 31, 20236Feb 8, 20233Feb 13, 20239
-2.46%Jan 4, 202210Jan 19, 202288May 25, 202298
-2.24%Feb 13, 202323Mar 17, 202336May 9, 202359
-1.30%Nov 26, 202118Dec 22, 20218Jan 4, 202226
-0.46%May 12, 20231May 15, 20231May 16, 20232
-0.40%Oct 28, 20219Nov 10, 202111Nov 26, 202120
-0.31%Sep 21, 20211Sep 22, 20214Sep 28, 20215
-0.21%Sep 29, 202111Oct 14, 20219Oct 27, 202120